(Q33705518)

28 July 2017

1 reference

title

Efficacy of anti-LT agents in the treatment of chronic asthma (English)

1 reference

28 July 2017

1 reference

Spector SL

1

1 reference

28 July 2017

language of work or name

1 reference

1 March 1999

1 reference

Clinical Reviews in Allergy & Immunology

28 July 2017

published in

1 reference

28 July 2017

volume

17

1 reference

28 July 2017

issue

1-2

1 reference

28 July 2017

page(s)

235-246

1 reference

Translocation of cytosolic phospholipase A2 to the nuclear envelope elicits topographically localized phospholipid hydrolysis

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02737607

Inhibition of leukotriene D4-induced bronchoconstriction in normal subjects by the oral LTD4 receptor antagonist ICI 204,219.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02737607

Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02737607

Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02737607

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02737607

Testing for human immunodeficiency virus infection in patients with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02737607

The Pivotal Role of 5-Lipoxygenase Products in the Reaction of Aspirin-sensitive Asthmatics to Aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02737607

Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist

21 January 2018

1 reference

12 December 2020

Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on classification and nomenclature.

1 reference

12 December 2020

Long-, intermediate- and short-term growth studies in asthmatic children treated with inhaled glucocorticosteroids

1 reference

12 December 2020

Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma

1 reference

12 December 2020

The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air

1 reference

12 December 2020

Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group

1 reference

12 December 2020

Leukotriene inhibitors and antagonists in asthma.

1 reference

12 December 2020

Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects

1 reference

12 December 2020

Use of inhaled corticosteroids and the risk of cataracts.

1 reference

12 December 2020

Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group

1 reference

12 December 2020

Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group

1 reference

12 December 2020

A randomized controlled trial comparing zileuton with theophylline in moderate asthma. The Zileuton Study Group

1 reference

12 December 2020

Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma

1 reference

12 December 2020

Leukotriene E4 and granulocytic infiltration into asthmatic airways

1 reference

12 December 2020

Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteers

1 reference

12 December 2020

Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02737607

1 reference

Dimensions Publication ID

28 July 2017

1043112895

0 references

1 reference